Your session is about to expire
← Back to Search
Continuous Glucose Monitoring for Gestational Diabetes (CAPO Trial)
CAPO Trial Summary
This trial will use continuous glucose monitoring to see if it lowers the rate of serious complications in women with A2 gestational diabetes.
CAPO Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowCAPO Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.CAPO Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am a woman aged between 18 and 50.The baby has known health problems before birth.My current pregnancy has been diagnosed with fetal growth restriction.You missed three or more prenatal visits before being diagnosed with A2 gestational diabetes.My current pregnancy has shown abnormal genetic test results for the fetus.I was diagnosed with gestational diabetes either before 24 weeks or after 36 weeks of pregnancy.I have been diagnosed with too much amniotic fluid.I have a health condition such as lupus, high blood pressure, cancer, or heart disease.You have diabetes before becoming pregnant.I have been diagnosed with gestational diabetes needing medication in my current pregnancy between 24-36 weeks.
- Group 1: Continuous Glucose Monitor
- Group 2: Routine Care
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any unfilled positions in this clinical trial that people can apply for?
"According to clinicaltrials.gov, this study is currently looking for volunteers and has been accepting applications since September 1st 2020 (last updated February 1st 2022)."
Is the study open to persons of advanced age?
"The minimal age requirement to be included in this research is 18 while the maximum cutoff point is 50."
What is the magnitude of participation in this clinical trial?
"Affirmative. The clinical trial, which was initiated on September 1st 2020 and last amended on February 1st 2022 is actively accepting participants from one medical centre. 80 prospects are needed to partake in the study."
How can I join this clinical experiment?
"To qualify for this study, individuals must have a diagnosis of diabetes mellitus and be between 18 to 50 years old. Presently, the clinical trial is looking to enlist 80 participants."
Share this study with friends
Copy Link
Messenger